Get started
Markets US Stocks Health Technology Medical Specialties

AngioDynamics, Inc ANGO

ANGO NASDAQ
ANGO
AngioDynamics, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals Forecast

ANGO Chart

Ideas

Moving Average/Support/Resistance Example
ANGO
, 1DEducation
ANGO: Moving Average/Support/Resistance Example

Here's a great example on how you can use a moving average to watch for trend reversals and to trigger trades in case you don't like drawing a lot of lines on your chart. In this example, when the 50 Moving Average (MA) crossed the 200MA in May 2019, it signaled a bearish reversal (known as a bearish cross). Later, in November 2020, it crossed again signaling a...

ANGO
ANGO
, 1DLong
ANGO: ANGO

ANGO

Interday Short- Great Reversal
ANGO
, 30Short
ANGO: Interday Short- Great Reversal

Shorting ANGO 3/4/2019 Entry: 23.24$ at 15:53 NY Time. Stop Size: 0.19$ Result: R/R 1:2 Trade Idea: Interday Reversal strategy (Powerful stock in the interday, "Healthy" Fibonacci Retracement, Price Retracing to a resistance level, Candlestick pattern Trigger). Tools: VWAP, EMA20, Pivot Points. Trigger: Dark Cloud Cover Candlestick pattern on the...

Support and Resistance
ANGO
, 1D
ANGO: Support and Resistance

Earnings are coming

ANOG: Small/Medium CFO/CEO- If They Buy, Might Want To Buy??
ANGO
, D
ANGO: ANOG: Small/Medium CFO/CEO- If They Buy, Might Want To Buy??

Published on July 24, 2017 at 2:32 pm by TIM FREDERICK in Insider Trading,Market Movers,News Two insiders at AngioDynamics, Inc. (NASDAQ:ANOG), including President and CEO James C. Clemmer, have bought shares of the company in the past week following a bout of weakness. Mr. Clemmer purchased 25,000 shares in total through transactions made on July 20 and 21,...

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Medical Specialties
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

News flow

More news